Skip to main content

Day: October 28, 2021

Regarding Networks segment income level of natural gas distribution for 2022

AB “Ignitis grupė” (hereinafter – the Group) informs that on 28 October 2021 National Energy Regulatory Council (hereinafter – NERC) adopted a resolution regarding the price caps for natural gas distribution services of AB “Energijos skirstymo operatorius” (hereinafter – ESO) for 2022 (hereinafter – the Resolution) (link in Lithuanian).  According to the NERC Resolution, the determined ESO’s income level for natural gas distribution services for 2022 amounts to EUR 44.6 million and is 12.5 % higher compared to the income level determined for the year 2021 (EUR 39.7 million). Considering the component sizes of depreciation and return on investments established in the certificate of the Resolution (link in Lithuanian), according to the assessment of the Group, this Resolution will not have a significant impact on the adjusted EBITDA for...

Continue reading

Regarding Networks segment income level of natural gas distribution for 2022

AB “Ignitis grupė” (hereinafter – the Group) informs that on 28 October 2021 National Energy Regulatory Council (hereinafter – NERC) adopted a resolution regarding the price caps for natural gas distribution services of AB “Energijos skirstymo operatorius” (hereinafter – ESO) for 2022 (hereinafter – the Resolution) (link in Lithuanian).  According to the NERC Resolution, the determined ESO’s income level for natural gas distribution services for 2022 amounts to EUR 44.6 million and is 12.5 % higher compared to the income level determined for the year 2021 (EUR 39.7 million). Considering the component sizes of depreciation and return on investments established in the certificate of the Resolution (link in Lithuanian), according to the assessment of the Group, this Resolution will not have a significant impact on the adjusted EBITDA for...

Continue reading

CHAR Advances New Biomass to Renewable Natural Gas Project to Produce 500,000 GJ/yr

TORONTO, Oct. 28, 2021 (GLOBE NEWSWIRE) — CHAR Technologies Ltd. (“CHAR” or “Company”) (YES – TSXV) is pleased to announce the commencement of surveying and geotechnical testing at the proposed site of its woody-biomass to renewable natural gas (“RNG”) High Temperature Pyrolysis (“HTP”) project near Kirkland Lake, Ontario. This project will potentially produce 500,000 gigajoules per year (GJ/yr) of RNG, and 10,000 tonnes per year of CHAR’s proprietary CleanFyre biocoal (“CleanFyre”). The Kirkland Lake project will be designed, built, operated and owned by CHAR. The Company had previously entered into a land purchase option agreement (July 2, 2021) with the town of Kirkland Lake with respect to the proposed project site, as well as a letter of interest (July 9, 2021) for biomass supply to the project, and an exclusive letter of...

Continue reading

Legends Business Group, Inc. Announces Acquisition

MESSAGE FROM PAUL BAKAJIN, CEO Henderson, NV, Oct. 28, 2021 (GLOBE NEWSWIRE) — Legends Business Group, Inc. (OTC Pink: LGBS) (“LGBS”) is excited to announce the acquisition of North Star Developers from AAP, Inc. (OTC Pink: AAPJ) (”AAPJ”). AAPJ will sell its 50% interest in North Star Developers to Legends Business Group, Inc. This acquisition is valued at $1.5 million dollars. AAPJ will receive 300,000,000 common shares of LGBS valued at .005 per share to complete the acquisition. This transaction is considered favorable for both companies. AAPJ has three operating businesses, so that their management has determined that it is in the company’s best interest to sell its 50% interest in North Star Developers to LGBS.  They feel that AAPJ’s investment in the very successful construction company, Red Tail Construction, warrants concentrating...

Continue reading

NanoVibronix CEO Brian Murphy Provides Business Update in Letter to Shareholders

Elmsford, NY, Oct. 28, 2021 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update and letter to shareholders from its Chief Executive Officer, Brian Murphy: “It is my sincere pleasure to address you through this letter and inform you of the progress, opportunities and potential of NanoVibronix. I hope to use this letter as a means to highlight the work we have done, but more importantly, the work we intend to do to build upon our success. As you may already be aware, I have worked in the medical device and medical biologics industry for over 30 years. My background is mostly commercialization of new technologies at various levels in each organization,...

Continue reading

FTC Solar to Announce Third Quarter 2021 Financial Results Wednesday, November 10, 2021

AUSTIN, Texas, Oct. 28, 2021 (GLOBE NEWSWIRE) — FTC Solar, Inc. (Nasdaq: FTCI), a global provider of solar tracker systems, software and engineering services, today announced it will report its third quarter 2021 financial results before market open on Wednesday, November 10, 2021. A conference call for members of the investment community will be held at 8:30 a.m. E.T. that same day, during which the Company will discuss its third quarter 2021 results, its outlook and other business items. This call will be webcast and can be accessed within the Investor Relations section of the FTC Solar corporate website at investor.ftcsolar.com. A replay of the conference call will also be available on the website for 30 days following the webcast. About FTC Solar, Inc.Founded in 2017 by a group of renewable energy industry veterans, FTC Solar...

Continue reading

Majedie Asset Management Ltd: Form 8.3 – [Insert name of offeree or offeror]

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION(a) Full name of discloser: Majedie Asset Management Limited(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.  (c) Name of offeror/offeree in relation to whose relevant securities this form relates:     Use a separate form for each offeror/offeree   Daily Mail & General Trust PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e) Date position held/dealing...

Continue reading

good natured® Announces Closing of Convertible Debenture Offering and Signing of Senior Credit Facility

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Oct. 28, 2021 (GLOBE NEWSWIRE) — good natured Products Inc. (the “Company” or “good natured®”) (TSX-V: GDNP) today announced that it has closed its previously announced public offering (the “Offering”) of convertible unsecured subordinated debentures (the “Debentures”), for aggregate gross proceeds of $17.25 million which includes the exercise in full by the underwriters of their over-allotment option to sell up to an additional $2.25 million principal amount of Debentures. The Offering was co-led by National Bank Financial Inc. and Beacon Securities Limited, with a syndicate including Canaccord Genuity Corp., Integral Wealth Securities Limited, Raymond James Ltd., Paradigm Capital Inc., and PI Financial Corp. The...

Continue reading

TFF Pharmaceuticals Receives Approval from Health Canada to Enter Human Clinical Trials for Inhaled Formulation of Niclosamide to Treat COVID-19

First Patient in Phase 1 Trial to be Dosed in November with Enrollment Completion Anticipated by Early Q1 2022 Preclinical Studies of Inhaled Dry Powder Formulation of Niclosamide Showed a Seven-Fold Reduction in Lung Viral Load in Hamsters When Administered 24 Hours After Inoculation with SARS-CoV-2 AUSTIN, Texas, Oct. 28, 2021 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it has received approval from Health Canada to begin a Phase 1 clinical trial of a dry powder formulation of niclosamide, an antiviral treatment with potential to address COVID-19 and other infectious diseases. The Phase 1 study was cleared by Health...

Continue reading

PurelyRx Launches Its Digital Pharmacy Logistics Administrative Portal Nationally

Manhattan, NY, Oct. 28, 2021 (GLOBE NEWSWIRE) — Healixa, Inc. (OTC Pink: EMOR) (“Healixa”, or the “Company”), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, is pleased to announce that they have launched its digital pharmacy logistics administrative portal nationally through PurelyRx. PurelyRx has been laser focused on building out a unique digital pharmacy logistics application. The company recently launched the Administrator Portal module for its clients. This feature was designed to support pharmacy operations growing need to service on-demand individual and batch prescription deliveries. Ian Parker, CEO of Healixa said, “The urgency and need for a product like the PurelyRx digital pharmacy delivery application...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.